FDA

Trang chủ » Phi Fda » FDA

Có thể bạn quan tâm

loader imageClose Menu Search Menu May 2025 BannerJanuary 2023 BannerMicrosoftTeams-image (5)MORESlideSlideSlide 1Learn MoreIECMORE previous arrownext arrow

PHP

21979539

PHP

50596932 View More PHP 21979539 PHP 50596932 View More

Featured Activity

  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐁𝐑𝐈𝐍𝐆𝐒 “𝐏𝐀𝐑𝐀 𝐊𝐀𝐘 𝐋𝐎𝐋𝐎, 𝐏𝐀𝐑𝐀 𝐊𝐀𝐘 𝐋𝐎𝐋𝐀 𝐂𝐀𝐑𝐀𝐕𝐀𝐍” 𝐓𝐎 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒

By Administrator 3 / September 4, 2025 As part of its continuing advocacy to reach out to communities, the Food and Drug Administration (FDA), in partnership... Read More Featured Activity || 𝐅𝐃𝐀 𝐁𝐑𝐈𝐍𝐆𝐒 “𝐏𝐀𝐑𝐀 𝐊𝐀𝐘 𝐋𝐎𝐋𝐎, 𝐏𝐀𝐑𝐀 𝐊𝐀𝐘 𝐋𝐎𝐋𝐀 𝐂𝐀𝐑𝐀𝐕𝐀𝐍” 𝐓𝐎 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒
  • Featured Activities

Featured Activity || 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐈𝐍𝐆 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐔𝐏𝐏𝐎𝐑𝐓: 𝐅𝐃𝐀’𝐒 𝐑𝐎𝐋𝐄 𝐈𝐍 𝐓𝐇𝐄 𝐌𝐒𝐌𝐄 𝐃𝐄𝐕𝐄𝐋𝐎𝐏𝐌𝐄𝐍𝐓 𝐏𝐋𝐀𝐍 𝟐𝟎𝟐𝟑–𝟐𝟎𝟐𝟖

By Administrator 3 / September 4, 2025 Baguio City – On 26 August 2025, the Food and Drug Administration (FDA) actively participated in the Department of... Read More Featured Activity || 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐈𝐍𝐆 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐔𝐏𝐏𝐎𝐑𝐓: 𝐅𝐃𝐀’𝐒 𝐑𝐎𝐋𝐄 𝐈𝐍 𝐓𝐇𝐄 𝐌𝐒𝐌𝐄 𝐃𝐄𝐕𝐄𝐋𝐎𝐏𝐌𝐄𝐍𝐓 𝐏𝐋𝐀𝐍 𝟐𝟎𝟐𝟑–𝟐𝟎𝟐𝟖
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐁𝐑𝐈𝐍𝐆𝐒 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐄𝐑𝐕𝐈𝐂𝐄𝐒 𝐂𝐋𝐎𝐒𝐄𝐑 𝐓𝐎 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐋𝐎𝐂𝐎𝐒 𝐒𝐔𝐑

By Administrator 3 / September 4, 2025 Candon City, Ilocos Sur – The Food and Drug Administration (FDA) took part in the Lab For All caravan... Read More Featured Activity || 𝐅𝐃𝐀 𝐁𝐑𝐈𝐍𝐆𝐒 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐄𝐑𝐕𝐈𝐂𝐄𝐒 𝐂𝐋𝐎𝐒𝐄𝐑 𝐓𝐎 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐋𝐎𝐂𝐎𝐒 𝐒𝐔𝐑
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐖𝐇𝐎: 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐈𝐍𝐆 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐘𝐒𝐓𝐄𝐌𝐒 𝐅𝐎𝐑 𝐀 𝐇𝐄𝐀𝐋𝐓𝐇𝐈𝐄𝐑 𝐅𝐔𝐓𝐔𝐑𝐄

By Administrator 3 / September 4, 2025 Manila City – On 4 August 2025, FDA Director General Paolo S. Teston welcomed Dr. Jinho Shin and Mr.... Read More Featured Activity || 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐖𝐇𝐎: 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐈𝐍𝐆 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐘𝐒𝐓𝐄𝐌𝐒 𝐅𝐎𝐑 𝐀 𝐇𝐄𝐀𝐋𝐓𝐇𝐈𝐄𝐑 𝐅𝐔𝐓𝐔𝐑𝐄
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐑𝐄𝐀𝐅𝐅𝐈𝐑𝐌𝐒 𝐂𝐎𝐌𝐌𝐈𝐓𝐌𝐄𝐍𝐓 𝐓𝐎 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐕𝐄 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐈𝐎𝐍 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐍 𝐒𝐀𝐍 𝐉𝐔𝐀𝐍 𝐂𝐈𝐓𝐘

By Administrator 3 / September 4, 2025 San Juan City – Last 26 August 2025, the Food and Drug Administration (FDA) participated in the Lab For... Read More Featured Activity || 𝐅𝐃𝐀 𝐑𝐄𝐀𝐅𝐅𝐈𝐑𝐌𝐒 𝐂𝐎𝐌𝐌𝐈𝐓𝐌𝐄𝐍𝐓 𝐓𝐎 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐕𝐄 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐈𝐎𝐍 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐍 𝐒𝐀𝐍 𝐉𝐔𝐀𝐍 𝐂𝐈𝐓𝐘
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐂𝐇𝐀𝐌𝐏𝐈𝐎𝐍𝐒 𝐇𝐎𝐍𝐄𝐒𝐓 𝐅𝐎𝐎𝐃 𝐋𝐀𝐁𝐄𝐋𝐒 𝐀𝐓 𝐄𝐂𝐂𝐏 𝐍𝐔𝐓𝐑𝐈𝐓𝐈𝐎𝐍 𝐅𝐎𝐑𝐔𝐌 𝟐𝟎𝟐𝟓

By Administrator 3 / September 4, 2025 Makati City — The Food and Drug Administration (FDA), through its Director General Paolo S. Teston, reaffirmed its commitment... Read More Featured Activity || 𝐅𝐃𝐀 𝐂𝐇𝐀𝐌𝐏𝐈𝐎𝐍𝐒 𝐇𝐎𝐍𝐄𝐒𝐓 𝐅𝐎𝐎𝐃 𝐋𝐀𝐁𝐄𝐋𝐒 𝐀𝐓 𝐄𝐂𝐂𝐏 𝐍𝐔𝐓𝐑𝐈𝐓𝐈𝐎𝐍 𝐅𝐎𝐑𝐔𝐌 𝟐𝟎𝟐𝟓
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐃𝐃𝐁 𝐑𝐄𝐈𝐍𝐅𝐎𝐑𝐂𝐄 𝐓𝐇𝐄𝐈𝐑 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐁𝐈𝐋𝐈𝐓𝐈𝐄𝐒 𝐀𝐒 𝐏𝐔𝐁𝐋𝐈𝐂 𝐇𝐄𝐀𝐋𝐓𝐇 𝐏𝐀𝐑𝐓𝐍𝐄𝐑𝐒 𝐈𝐍 𝐏𝐑𝐎𝐌𝐎𝐓𝐈𝐍𝐆 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐁𝐋𝐄 𝐔𝐒𝐄 𝐎𝐅 𝐒𝐔𝐁𝐒𝐓𝐀𝐍𝐂𝐄𝐒

By Administrator 3 / September 4, 2025 Quezon City – On 30 July 2025, the Food and Drug Administration (FDA), headed by Director General Paolo S.... Read More Featured Activity || 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐃𝐃𝐁 𝐑𝐄𝐈𝐍𝐅𝐎𝐑𝐂𝐄 𝐓𝐇𝐄𝐈𝐑 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐁𝐈𝐋𝐈𝐓𝐈𝐄𝐒 𝐀𝐒 𝐏𝐔𝐁𝐋𝐈𝐂 𝐇𝐄𝐀𝐋𝐓𝐇 𝐏𝐀𝐑𝐓𝐍𝐄𝐑𝐒 𝐈𝐍 𝐏𝐑𝐎𝐌𝐎𝐓𝐈𝐍𝐆 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐁𝐋𝐄 𝐔𝐒𝐄 𝐎𝐅 𝐒𝐔𝐁𝐒𝐓𝐀𝐍𝐂𝐄𝐒
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐒 𝐋𝐀𝐁𝐎𝐑𝐀𝐓𝐎𝐑𝐘 𝐂𝐎𝐌𝐏𝐄𝐓𝐄𝐍𝐂𝐘 𝐓𝐇𝐑𝐎𝐔𝐆𝐇 𝐒𝐓𝐄𝐑𝐈𝐋𝐈𝐓𝐘 𝐓𝐄𝐒𝐓𝐈𝐍𝐆 𝐓𝐑𝐀𝐈𝐍𝐈𝐍𝐆 𝐖𝐈𝐓𝐇 𝐆𝐋𝐎𝐁𝐀𝐋 𝐄𝐗𝐏𝐄𝐑𝐓𝐒

By Administrator 3 / September 4, 2025 Alabang, Muntinlupa – As part of its continuing efforts to strengthen regulatory capacity and laboratory competency, the Food and... Read More Featured Activity || 𝐅𝐃𝐀 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐒 𝐋𝐀𝐁𝐎𝐑𝐀𝐓𝐎𝐑𝐘 𝐂𝐎𝐌𝐏𝐄𝐓𝐄𝐍𝐂𝐘 𝐓𝐇𝐑𝐎𝐔𝐆𝐇 𝐒𝐓𝐄𝐑𝐈𝐋𝐈𝐓𝐘 𝐓𝐄𝐒𝐓𝐈𝐍𝐆 𝐓𝐑𝐀𝐈𝐍𝐈𝐍𝐆 𝐖𝐈𝐓𝐇 𝐆𝐋𝐎𝐁𝐀𝐋 𝐄𝐗𝐏𝐄𝐑𝐓𝐒
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐉𝐎𝐈𝐍𝐒 𝐓𝐇𝐄 𝐍𝐀𝐓𝐈𝐎𝐍𝐀𝐋 𝐌𝐒𝐌𝐄 𝐖𝐄𝐄𝐊 𝐂𝐄𝐋𝐄𝐁𝐑𝐀𝐓𝐈𝐎𝐍

By Administrator 3 / September 4, 2025 Pasay City – In celebration of National MSME Week 2025, with the theme “Asenso Negosyo, Angat Kabuhayan: Bagong Pilipinas,”... Read More Featured Activity || 𝐅𝐃𝐀 𝐉𝐎𝐈𝐍𝐒 𝐓𝐇𝐄 𝐍𝐀𝐓𝐈𝐎𝐍𝐀𝐋 𝐌𝐒𝐌𝐄 𝐖𝐄𝐄𝐊 𝐂𝐄𝐋𝐄𝐁𝐑𝐀𝐓𝐈𝐎𝐍
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐒 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐘 𝐄𝐍𝐆𝐀𝐆𝐄𝐌𝐄𝐍𝐓 𝐀𝐓 𝐓𝐇𝐄 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐌𝐀𝐋𝐀𝐁𝐎𝐍 𝐂𝐀𝐑𝐀𝐕𝐀𝐍

By Administrator 3 / September 4, 2025 Malabon City – On Tuesday, 25 July 2025, the Food and Drug Administration (FDA) participated in the Lab For... Read More Featured Activity || 𝐅𝐃𝐀 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐒 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐘 𝐄𝐍𝐆𝐀𝐆𝐄𝐌𝐄𝐍𝐓 𝐀𝐓 𝐓𝐇𝐄 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐌𝐀𝐋𝐀𝐁𝐎𝐍 𝐂𝐀𝐑𝐀𝐕𝐀𝐍 View More

Featured Event

Play Play Play Play Play Play Play Play Previous Next View More

Featured Video

Play Play Play Play Play Play Play Play Play Play Play Previous Next

Featured Activity

  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐁𝐑𝐈𝐍𝐆𝐒 “𝐏𝐀𝐑𝐀 𝐊𝐀𝐘 𝐋𝐎𝐋𝐎, 𝐏𝐀𝐑𝐀 𝐊𝐀𝐘 𝐋𝐎𝐋𝐀 𝐂𝐀𝐑𝐀𝐕𝐀𝐍” 𝐓𝐎 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒

By Administrator 3 / September 4, 2025 As part of its continuing advocacy to reach out to communities, the Food and Drug Administration (FDA), in partnership... Read More Featured Activity || 𝐅𝐃𝐀 𝐁𝐑𝐈𝐍𝐆𝐒 “𝐏𝐀𝐑𝐀 𝐊𝐀𝐘 𝐋𝐎𝐋𝐎, 𝐏𝐀𝐑𝐀 𝐊𝐀𝐘 𝐋𝐎𝐋𝐀 𝐂𝐀𝐑𝐀𝐕𝐀𝐍” 𝐓𝐎 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒
  • Featured Activities

Featured Activity || 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐈𝐍𝐆 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐔𝐏𝐏𝐎𝐑𝐓: 𝐅𝐃𝐀’𝐒 𝐑𝐎𝐋𝐄 𝐈𝐍 𝐓𝐇𝐄 𝐌𝐒𝐌𝐄 𝐃𝐄𝐕𝐄𝐋𝐎𝐏𝐌𝐄𝐍𝐓 𝐏𝐋𝐀𝐍 𝟐𝟎𝟐𝟑–𝟐𝟎𝟐𝟖

By Administrator 3 / September 4, 2025 Baguio City – On 26 August 2025, the Food and Drug Administration (FDA) actively participated in the Department of... Read More Featured Activity || 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐈𝐍𝐆 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐔𝐏𝐏𝐎𝐑𝐓: 𝐅𝐃𝐀’𝐒 𝐑𝐎𝐋𝐄 𝐈𝐍 𝐓𝐇𝐄 𝐌𝐒𝐌𝐄 𝐃𝐄𝐕𝐄𝐋𝐎𝐏𝐌𝐄𝐍𝐓 𝐏𝐋𝐀𝐍 𝟐𝟎𝟐𝟑–𝟐𝟎𝟐𝟖
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐁𝐑𝐈𝐍𝐆𝐒 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐄𝐑𝐕𝐈𝐂𝐄𝐒 𝐂𝐋𝐎𝐒𝐄𝐑 𝐓𝐎 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐋𝐎𝐂𝐎𝐒 𝐒𝐔𝐑

By Administrator 3 / September 4, 2025 Candon City, Ilocos Sur – The Food and Drug Administration (FDA) took part in the Lab For All caravan... Read More Featured Activity || 𝐅𝐃𝐀 𝐁𝐑𝐈𝐍𝐆𝐒 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐄𝐑𝐕𝐈𝐂𝐄𝐒 𝐂𝐋𝐎𝐒𝐄𝐑 𝐓𝐎 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐋𝐎𝐂𝐎𝐒 𝐒𝐔𝐑
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐖𝐇𝐎: 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐈𝐍𝐆 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐘𝐒𝐓𝐄𝐌𝐒 𝐅𝐎𝐑 𝐀 𝐇𝐄𝐀𝐋𝐓𝐇𝐈𝐄𝐑 𝐅𝐔𝐓𝐔𝐑𝐄

By Administrator 3 / September 4, 2025 Manila City – On 4 August 2025, FDA Director General Paolo S. Teston welcomed Dr. Jinho Shin and Mr.... Read More Featured Activity || 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐖𝐇𝐎: 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐈𝐍𝐆 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐘𝐒𝐓𝐄𝐌𝐒 𝐅𝐎𝐑 𝐀 𝐇𝐄𝐀𝐋𝐓𝐇𝐈𝐄𝐑 𝐅𝐔𝐓𝐔𝐑𝐄
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐑𝐄𝐀𝐅𝐅𝐈𝐑𝐌𝐒 𝐂𝐎𝐌𝐌𝐈𝐓𝐌𝐄𝐍𝐓 𝐓𝐎 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐕𝐄 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐈𝐎𝐍 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐍 𝐒𝐀𝐍 𝐉𝐔𝐀𝐍 𝐂𝐈𝐓𝐘

By Administrator 3 / September 4, 2025 San Juan City – Last 26 August 2025, the Food and Drug Administration (FDA) participated in the Lab For... Read More Featured Activity || 𝐅𝐃𝐀 𝐑𝐄𝐀𝐅𝐅𝐈𝐑𝐌𝐒 𝐂𝐎𝐌𝐌𝐈𝐓𝐌𝐄𝐍𝐓 𝐓𝐎 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐕𝐄 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐈𝐎𝐍 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐍 𝐒𝐀𝐍 𝐉𝐔𝐀𝐍 𝐂𝐈𝐓𝐘
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐂𝐇𝐀𝐌𝐏𝐈𝐎𝐍𝐒 𝐇𝐎𝐍𝐄𝐒𝐓 𝐅𝐎𝐎𝐃 𝐋𝐀𝐁𝐄𝐋𝐒 𝐀𝐓 𝐄𝐂𝐂𝐏 𝐍𝐔𝐓𝐑𝐈𝐓𝐈𝐎𝐍 𝐅𝐎𝐑𝐔𝐌 𝟐𝟎𝟐𝟓

By Administrator 3 / September 4, 2025 Makati City — The Food and Drug Administration (FDA), through its Director General Paolo S. Teston, reaffirmed its commitment... Read More Featured Activity || 𝐅𝐃𝐀 𝐂𝐇𝐀𝐌𝐏𝐈𝐎𝐍𝐒 𝐇𝐎𝐍𝐄𝐒𝐓 𝐅𝐎𝐎𝐃 𝐋𝐀𝐁𝐄𝐋𝐒 𝐀𝐓 𝐄𝐂𝐂𝐏 𝐍𝐔𝐓𝐑𝐈𝐓𝐈𝐎𝐍 𝐅𝐎𝐑𝐔𝐌 𝟐𝟎𝟐𝟓
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐃𝐃𝐁 𝐑𝐄𝐈𝐍𝐅𝐎𝐑𝐂𝐄 𝐓𝐇𝐄𝐈𝐑 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐁𝐈𝐋𝐈𝐓𝐈𝐄𝐒 𝐀𝐒 𝐏𝐔𝐁𝐋𝐈𝐂 𝐇𝐄𝐀𝐋𝐓𝐇 𝐏𝐀𝐑𝐓𝐍𝐄𝐑𝐒 𝐈𝐍 𝐏𝐑𝐎𝐌𝐎𝐓𝐈𝐍𝐆 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐁𝐋𝐄 𝐔𝐒𝐄 𝐎𝐅 𝐒𝐔𝐁𝐒𝐓𝐀𝐍𝐂𝐄𝐒

By Administrator 3 / September 4, 2025 Quezon City – On 30 July 2025, the Food and Drug Administration (FDA), headed by Director General Paolo S.... Read More Featured Activity || 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐃𝐃𝐁 𝐑𝐄𝐈𝐍𝐅𝐎𝐑𝐂𝐄 𝐓𝐇𝐄𝐈𝐑 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐁𝐈𝐋𝐈𝐓𝐈𝐄𝐒 𝐀𝐒 𝐏𝐔𝐁𝐋𝐈𝐂 𝐇𝐄𝐀𝐋𝐓𝐇 𝐏𝐀𝐑𝐓𝐍𝐄𝐑𝐒 𝐈𝐍 𝐏𝐑𝐎𝐌𝐎𝐓𝐈𝐍𝐆 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐁𝐋𝐄 𝐔𝐒𝐄 𝐎𝐅 𝐒𝐔𝐁𝐒𝐓𝐀𝐍𝐂𝐄𝐒
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐒 𝐋𝐀𝐁𝐎𝐑𝐀𝐓𝐎𝐑𝐘 𝐂𝐎𝐌𝐏𝐄𝐓𝐄𝐍𝐂𝐘 𝐓𝐇𝐑𝐎𝐔𝐆𝐇 𝐒𝐓𝐄𝐑𝐈𝐋𝐈𝐓𝐘 𝐓𝐄𝐒𝐓𝐈𝐍𝐆 𝐓𝐑𝐀𝐈𝐍𝐈𝐍𝐆 𝐖𝐈𝐓𝐇 𝐆𝐋𝐎𝐁𝐀𝐋 𝐄𝐗𝐏𝐄𝐑𝐓𝐒

By Administrator 3 / September 4, 2025 Alabang, Muntinlupa – As part of its continuing efforts to strengthen regulatory capacity and laboratory competency, the Food and... Read More Featured Activity || 𝐅𝐃𝐀 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐒 𝐋𝐀𝐁𝐎𝐑𝐀𝐓𝐎𝐑𝐘 𝐂𝐎𝐌𝐏𝐄𝐓𝐄𝐍𝐂𝐘 𝐓𝐇𝐑𝐎𝐔𝐆𝐇 𝐒𝐓𝐄𝐑𝐈𝐋𝐈𝐓𝐘 𝐓𝐄𝐒𝐓𝐈𝐍𝐆 𝐓𝐑𝐀𝐈𝐍𝐈𝐍𝐆 𝐖𝐈𝐓𝐇 𝐆𝐋𝐎𝐁𝐀𝐋 𝐄𝐗𝐏𝐄𝐑𝐓𝐒
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐉𝐎𝐈𝐍𝐒 𝐓𝐇𝐄 𝐍𝐀𝐓𝐈𝐎𝐍𝐀𝐋 𝐌𝐒𝐌𝐄 𝐖𝐄𝐄𝐊 𝐂𝐄𝐋𝐄𝐁𝐑𝐀𝐓𝐈𝐎𝐍

By Administrator 3 / September 4, 2025 Pasay City – In celebration of National MSME Week 2025, with the theme “Asenso Negosyo, Angat Kabuhayan: Bagong Pilipinas,”... Read More Featured Activity || 𝐅𝐃𝐀 𝐉𝐎𝐈𝐍𝐒 𝐓𝐇𝐄 𝐍𝐀𝐓𝐈𝐎𝐍𝐀𝐋 𝐌𝐒𝐌𝐄 𝐖𝐄𝐄𝐊 𝐂𝐄𝐋𝐄𝐁𝐑𝐀𝐓𝐈𝐎𝐍
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐒 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐘 𝐄𝐍𝐆𝐀𝐆𝐄𝐌𝐄𝐍𝐓 𝐀𝐓 𝐓𝐇𝐄 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐌𝐀𝐋𝐀𝐁𝐎𝐍 𝐂𝐀𝐑𝐀𝐕𝐀𝐍

By Administrator 3 / September 4, 2025 Malabon City – On Tuesday, 25 July 2025, the Food and Drug Administration (FDA) participated in the Lab For... Read More Featured Activity || 𝐅𝐃𝐀 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐒 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐘 𝐄𝐍𝐆𝐀𝐆𝐄𝐌𝐄𝐍𝐓 𝐀𝐓 𝐓𝐇𝐄 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐌𝐀𝐋𝐀𝐁𝐎𝐍 𝐂𝐀𝐑𝐀𝐕𝐀𝐍 View More

Featured Event

Play Play Play Play Play Play Play Play Play Play Previous Next View More

Featured Video

Play Play Play Play Play Play Play Play Play Play Play Previous Next Our Services

For Products and Establishments registration at FDA

Verification Portal

Check the List of Approved FDA Authorizations

Go to Verification Portal

eServices Portal

New Online Application System for FDA Authorizations

Go to eServices

ePortal System

Apply and Register for License to Operate, Certificate of Product Registration, and other FDA Authorizations

Go to ePortal

ePortal v.2 System

Authorizations for HUHS and Novel Tobacco Products

Go to ePortal v.2

RRDportal

Applications for Licensing and Registration of Radiation Facilities and Other Related Authorizations

Go to RRDportal
Verification Portal

Verification Portal

Check the List of Approved FDA Authorizations

Go to Verification Portal
eServices

eServices Portal

New Online Application System for FDA Authorizations

Go to eServices
ePortal

ePortal System

Apply and Register for License to Operate, Certificate of Product Registration, and other FDA Authorizations

Go to ePortal
v2 ePorta1

ePortal v.2 System

Authorizations for HUHS and Novel Tobacco Products

Go to ePortal v.2
RRDportal_icon

RRDportal

Applications for Licensing and Registration of Radiation Facilities and Other Related Authorizations

Go to RRDportal

COVID19-related Updates

(Click Logo below for Updates)

Latest Advisories

FDA Advisory No.2025-1536 || Product Recall of Specific Products Manufactured by Ace Pharmaceuticals, Inc. from July 2023 to 24 April 2025
  • Drugs Advisories

FDA Advisory No.2025-1536 || Product Recall of Specific Products Manufactured by Ace Pharmaceuticals, Inc. from July 2023 to 24 April 2025

January 8, 2026 All healthcare professionals and the general public are hereby warned by the Food and Drug Administration (FDA) that the affected... Read More FDA Advisory No.2025-1607 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “OTOKI Fluffy Cooked White Rice”
  • Food Advisories

FDA Advisory No.2025-1607 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “OTOKI Fluffy Cooked White Rice”

January 8, 2026 The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the... Read More FDA Advisory No.2025-1606 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “SEMPIO Soondubu Jjigae Spicy Tofu Stew Sauce (In Foreign Language)”
  • Food Advisories

FDA Advisory No.2025-1606 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “SEMPIO Soondubu Jjigae Spicy Tofu Stew Sauce (In Foreign Language)”

January 8, 2026 The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the... Read More FDA Advisory No.2025-1574 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “TAC TAC Super Sour”
  • Food Advisories

FDA Advisory No.2025-1574 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “TAC TAC Super Sour”

January 8, 2026 The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the... Read More FDA Advisory No.2025-1573 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “FIBRA+ Whole Wheat Flour Coarse”
  • Food Advisories

FDA Advisory No.2025-1573 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “FIBRA+ Whole Wheat Flour Coarse”

January 8, 2026 The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the... Read More FDA Advisory No.2025-1572 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “FREDDI BARBIE Soft Mini-Cakes with Strawberry-Yogurt Filling”
  • Food Advisories

FDA Advisory No.2025-1572 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “FREDDI BARBIE Soft Mini-Cakes with Strawberry-Yogurt Filling”

January 8, 2026 The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the... Read More FDA Advisory No.2025-1571 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “MARUCHO Roasted Peanuts Tom Yung Kung Flavour Coated”
  • Food Advisories

FDA Advisory No.2025-1571 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “MARUCHO Roasted Peanuts Tom Yung Kung Flavour Coated”

January 8, 2026 The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the... Read More FDA Advisory No.2025-1570 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “KOPINAS Turmeric Tea Drink Mix”
  • Food Advisories

FDA Advisory No.2025-1570 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “KOPINAS Turmeric Tea Drink Mix”

January 7, 2026 The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the... Read More FDA Advisory No.2025-1569 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “MARUCHO Mayonnaise Wasabi Flavour Marucho Brand Roasted Peanuts Mayonnaise Wasabi Flavour Coated”
  • Food Advisories

FDA Advisory No.2025-1569 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “MARUCHO Mayonnaise Wasabi Flavour Marucho Brand Roasted Peanuts Mayonnaise Wasabi Flavour Coated”

January 7, 2026 The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the... Read More FDA Advisory No.2025-0509-A || AMENDMENT TO FDA ADVISORY NO. 2025-0509 ENTITLED, “REGULATORY UPDATES FOR HOUSEHOLD/URBAN HAZARDOUS SUBSTANCES (HUHS)”
  • Cosmetic Advisories

FDA Advisory No.2025-0509-A || AMENDMENT TO FDA ADVISORY NO. 2025-0509 ENTITLED, “REGULATORY UPDATES FOR HOUSEHOLD/URBAN HAZARDOUS SUBSTANCES (HUHS)”

January 7, 2026 The Food and Drug Administration (FDA), through the Center for Cosmetics and Household/Urban Hazardous Substances Regulation and Research (CCHUHSRR), is... Read More View More

Announcement

Announcement || FEEDBACK ON THE CONSOLIDATED COMMENTS FOR PROPOSED ISSUANCE || Amendment to FDA Circular No. 2021-011-A, entitled, “Extension of Transitory Period and Provision of Interim Guidelines for Product Registration, including the Labeling Requirements, for Household/Urban Hazardous Substances”
In reference to the previously conducted solicitation of comments on the proposed FDA Circular, entitled “Amendment to FDA Circular No ...Read More December 15, 2025
Announcement || DRAFT FOR COMMENTS: Guidelines for the Recognition of Radiation Protection Officers (RPO) and Qualified Experts (QE) for Ionizing Radiation Facilities under FDA
The Center for Device Regulation, Radiation Health, and Research (CDRRHR) hereby circulates the latest draft of the proposed FDA Circular ...Read More December 11, 2025
  • 1
  • 2
  • 3
  • …
  • 376
  • ›
Loading...

FDA on the News

FDA on the News || QC gov’t at FDA sanib pwersa para palakasin ang MSMEs
  • FDA on the News

FDA on the News || QC gov’t at FDA sanib pwersa para palakasin ang MSMEs

April 17, 2023 Nakipagsanib puwersa ang lokal na pamahalaan ng Quezon City sa Food and Drug Administration para palakasin pa ang Micro, Small,... Read More FDA on the News || LGU, FDA kapit-bisig sa pagpapalago sa MSMEs sa QC
  • FDA on the News

FDA on the News || LGU, FDA kapit-bisig sa pagpapalago sa MSMEs sa QC

April 17, 2023 MANILA, Philippines – NAIS palawakin pa ng Quezon City Local Governmemt ang suporta para sa mga Micro Small and Medium... Read More FDA on the News || QC, FDA ink assistance agreement for MSMEs
  • FDA on the News

FDA on the News || QC, FDA ink assistance agreement for MSMEs

April 17, 2023 The Quezon City government and the Food and Drug Administration (FDA) signed on Friday, April 14, a memorandum of agreement... Read More FDA on the News || QC gov’t partners with FDA to aid MSMEs
  • FDA on the News

FDA on the News || QC gov’t partners with FDA to aid MSMEs

April 17, 2023 MANILA, Philippines — The Quezon City government has joined forces with the Food and Drugs Administration (FDA) to support micro,... Read More FDA on the News || QC, FDA ink agreement to aid MSMEs
  • FDA on the News

FDA on the News || QC, FDA ink agreement to aid MSMEs

April 17, 2023 MANILA – The Quezon City local government and the Food and Drug Administration (FDA) have agreed to work together to help... Read More FDA on the News || QC, FDA partner on micro business development
  • FDA on the News

FDA on the News || QC, FDA partner on micro business development

April 17, 2023 In a bid to help micro, small and medium enterprises (MSMEs), the Quezon City government on Friday partnered with the... Read More FDA on the News || Quezon City LGU at FDA, kapit-bisig sa pagpapalago ng MSMEs
  • FDA on the News

FDA on the News || Quezon City LGU at FDA, kapit-bisig sa pagpapalago ng MSMEs

April 17, 2023 MANILA, Philippines — Palalawakin pa ng Quezon City Local Government ang suporta para sa mga Micro Small and Medium Enterprises... Read More FDA on the News || Quezon City, FDA to help MSMEs create more jobs (MANILA TIMES)
  • FDA on the News

FDA on the News || Quezon City, FDA to help MSMEs create more jobs (MANILA TIMES)

April 17, 2023 QUEZON City Mayor Maria Josefina "Joy" Belmonte on Friday announced that the local government has joined forces with the Food... Read More FDA on the News || The Quezon City government yesterday partnered with the Food and Drug Administration (FDA) to provide technical assistance and training for micro, small and medium enterprises (MSMEs) in the city.
  • FDA on the News

FDA on the News || The Quezon City government yesterday partnered with the Food and Drug Administration (FDA) to provide technical assistance and training for micro, small and medium enterprises (MSMEs) in the city.

April 17, 2023 The partnership is part of the city’s Bigyang-Halaga, Bangon MSMEs (BBMSME) program, which aims to streamline registration processes and make... Read More FDA on the News || SMNI News: Quezon City at FDA, lumagda ng kasunduan upang tulungan ang MSMEs
  • FDA on the News

FDA on the News || SMNI News: Quezon City at FDA, lumagda ng kasunduan upang tulungan ang MSMEs

April 17, 2023 Mabibigyan ng pagkakataon ang mga Micro, Small, and Medium Enterprises ng Lungsod ng Quezon na mapadali at maintindihan ang pagkakaroon... Read More View More

Press Statements

FDA Press Statement || FDA Reaffirms Commitment to Strengthening Transparency and Efficiency
  • Press Statement

FDA Press Statement || FDA Reaffirms Commitment to Strengthening Transparency and Efficiency

June 3, 2025 Alabang, Muntinlupa City — The Food and Drug Administration (FDA), following the initiative of Director General Paolo S. Teston,... Read More FDA Press Statement || FDA Actively Participates During the 2025 USP Convention
  • Press Statement

FDA Press Statement || FDA Actively Participates During the 2025 USP Convention

June 3, 2025 Washington D.C., U.S.A. — To strengthen its global commitment to pharmaceutical excellence and public health, the Food and Drug... Read More FDA Press Statement || FDA Director General Urges Suspension of New Regulatory Fees
  • Press Statement

FDA Press Statement || FDA Director General Urges Suspension of New Regulatory Fees

May 29, 2025 Quezon City — The Food and Drug Administration (FDA) urges the Department of Health to approve the immediate suspension... Read More FDA Press Statement || DOH USEC. ATTY. PAOLO S. TESTON OFFICIALLY TAKES THE HELM AS FDA DIRECTOR GENERAL, VOWS TO RESTORE PUBLIC TRUST AND STRENGTHEN THE AGENCY’S SERVICE TO THE NATION
  • Press Statement

FDA Press Statement || DOH USEC. ATTY. PAOLO S. TESTON OFFICIALLY TAKES THE HELM AS FDA DIRECTOR GENERAL, VOWS TO RESTORE PUBLIC TRUST AND STRENGTHEN THE AGENCY’S SERVICE TO THE NATION

May 15, 2025 Alabang, Muntinlupa City — May 13, 2025 The Food and Drug Administration (FDA) of the Philippines welcomed its... Read More FDA Press Statement || FDA Addresses Regulatory Concerns and Promotes Streamlined Processes in PAPPI Seminar
  • Press Statement

FDA Press Statement || FDA Addresses Regulatory Concerns and Promotes Streamlined Processes in PAPPI Seminar

April 23, 2025 The Food and Drug Administration (FDA) actively participated in the 1st Quarter Seminar of the Philippine Association of Pharmacists in... Read More FDA Press Statement || FDA PARTNERS WITH BICOL SUCs TO BOOST MSME GROWTH
  • Press Statement

FDA Press Statement || FDA PARTNERS WITH BICOL SUCs TO BOOST MSME GROWTH

April 23, 2025 The Food and Drug Administration (FDA) has actively collaborated with State Universities and Colleges (SUCs) in the Bicol Region... Read More FDA Press Statement || FDA Joins LAB for ALL Program in Teresa, Rizal
  • Press Statement

FDA Press Statement || FDA Joins LAB for ALL Program in Teresa, Rizal

April 23, 2025 The Food and Drug Administration (FDA), under the leadership of Director General Dr. Samuel A. Zacate, reaffirmed its continued... Read More FDA Press Statement || FDA and Malolos City Government Forge Partnership in Support of MSMEs
  • Press Statement

FDA Press Statement || FDA and Malolos City Government Forge Partnership in Support of MSMEs

April 23, 2025 The Food and Drug Administration (FDA) and the City Government of Malolos marked a significant milestone with the ceremonial... Read More FDA Press Statement || THE FUTURE OF PHILIPPINE COSMETICS: OPENING REGULATORY PATHWAYS FOR FUNCTIONAL COSMETICS AND QUASI DRUGS
  • Press Statement

FDA Press Statement || THE FUTURE OF PHILIPPINE COSMETICS: OPENING REGULATORY PATHWAYS FOR FUNCTIONAL COSMETICS AND QUASI DRUGS

April 8, 2025 April 3, 2025 | Alabang, Muntinlupa City – The Philippine Food and Drug Administration (PH-FDA) and the Ministry of... Read More FDA Press Statement || FDA OPLAN KATHAROS LEADS DISPOSAL OF SEIZED VIOLATIVE HEALTH PRODUCTS IN MINDANAO EAST CLUSTER
  • Press Statement

FDA Press Statement || FDA OPLAN KATHAROS LEADS DISPOSAL OF SEIZED VIOLATIVE HEALTH PRODUCTS IN MINDANAO EAST CLUSTER

April 8, 2025 The Food and Drug Administration (FDA) under the leadership of Director General Dr. Samuel A. Zacate, successfully disposed an... Read More View More Transparency-Seal Image Click Redirect FOI Citizens-Charter GAD Verification-Logo Pharmacovigilance Pharmacovigilance

Draft for Comments

  • Draft for Comments

Draft for Comments || Guidelines on the Use of Acceptable Nutrition and Health Claims in the Labeling, Advertisement, Sponsorships, Promotions, and Other Marketing Activities of Prepackaged Processed Food Products

December 17, 2025 All comments shall be sent to [email protected]. The deadline for submission of comments is on 15 January 2026. I. BACKGROUND The... Read More Draft for Comments || Guidelines on the Use of Acceptable Nutrition and Health Claims in the Labeling, Advertisement, Sponsorships, Promotions, and Other Marketing Activities of Prepackaged Processed Food Products
  • Draft for Comments

Draft for Comments || Operational Procedures on the Application for Sales Promotion Permit with the Food and Drug Administration

December 11, 2025 Deadline for commenting: 12 January 2026 All comments shall be submitted in MSWord and pdf file formats to [email protected] using... Read More Draft for Comments || Operational Procedures on the Application for Sales Promotion Permit with the Food and Drug Administration
  • Device Announcements
  • Draft for Comments
  • General Announcements

Announcement || DRAFT FOR COMMENTS: Guidelines for the Recognition of Radiation Protection Officers (RPO) and Qualified Experts (QE) for Ionizing Radiation Facilities under FDA

December 11, 2025 The Center for Device Regulation, Radiation Health, and Research (CDRRHR) hereby circulates the latest draft of the proposed FDA Circular... Read More Announcement || DRAFT FOR COMMENTS: Guidelines for the Recognition of Radiation Protection Officers (RPO) and Qualified Experts (QE) for Ionizing Radiation Facilities under FDA
  • Draft for Comments

Draft for Comments || Amendment to Administrative Order No. 2024-0016 entitled “Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration”

November 26, 2025 The Policy and Planning Office (PPO) is hereby circulating the updated draft of the proposed Administrative Order, provisionally entitled “Amendment... Read More Draft for Comments || Amendment to Administrative Order No. 2024-0016 entitled “Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration”
  • Draft for Comments

Draft for Comments || Guidelines on the Qualification Criteria for Grouping of Medical Devices in Product Registration

November 12, 2025 I .BACKGROUND The field of medical devices has witnessed remarkable advancements over the years, with an ever-expanding range of innovative... Read More Draft for Comments || Guidelines on the Qualification Criteria for Grouping of Medical Devices in Product Registration
  • Draft for Comments

Draft for Comments || Implementing Guidelines on the Post-Approval Changes of Registered Pharmaceutical Products for Human Use in Accordance with Administrative Order No. 2024-0013 “General Rules and Regulations on the Registration of Pharmaceutical Products and Active Pharmaceutical Ingredients Intended for Human Use”

October 24, 2025 All concerned stakeholders are hereby informed that the period for the submission of comments on the draft FDA Circular is... Read More Draft for Comments || Implementing Guidelines on the Post-Approval Changes of Registered Pharmaceutical Products for Human Use in Accordance with Administrative Order No. 2024-0013 “General Rules and Regulations on the Registration of Pharmaceutical Products and Active Pharmaceutical Ingredients Intended for Human Use”
  • Draft for Comments

Draft for Comments || Guidelines on the Application for Variation of the Issued Authorizations for Medical and Health-Related Devices

October 17, 2025 All comments may be sent to [email protected] using the template provided. The deadline for submission of comments is on 21... Read More Draft for Comments || Guidelines on the Application for Variation of the Issued Authorizations for Medical and Health-Related Devices
  • Draft for Comments

Draft for Comments || Rules and Regulations Governing the Issuance of Authorizations for Toys and Childcare Articles

October 10, 2025 The Center for Cosmetics and Household/Urban Hazardous Substances Regulation and Research (CCHUHSRR) is hereby circulating the updated draft of the... Read More Draft for Comments || Rules and Regulations Governing the Issuance of Authorizations for Toys and Childcare Articles
  • Draft for Comments

Draft for Comments || Guidelines on the Inspection of Medical Device Establishments

October 8, 2025 I. BACKGROUND Republic Act (RA) No. 3720, entitled “Food, Drug and Cosmetic Act,” as amended by Executive Order No. 175... Read More Draft for Comments || Guidelines on the Inspection of Medical Device Establishments
  • Draft for Comments

Draft for Comments || Guidelines on the Institutionalization of Green Lane for Authorization of Health Establishments and Health Products under the Strategic Investments and Tatak Pinoy Initiatives Covered by the Food and Drug Administration (FDA)

October 8, 2025 Please submit your comments/inputs in MS word format via email to [email protected]. The deadline for submission of comments is on... Read More Draft for Comments || Guidelines on the Institutionalization of Green Lane for Authorization of Health Establishments and Health Products under the Strategic Investments and Tatak Pinoy Initiatives Covered by the Food and Drug Administration (FDA) View More

Bids and Awards

  • ITB and RFQ

NP-SVP-2025-019-MIN || Procurement for the Supply and Delivery of Parts and Supplies for the vehicles of FDA (Per lot)

December 22, 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Supply and Delivery of Parts and Supplies for the vehicles of... Read More NP-SVP-2025-019-MIN || Procurement for the Supply and Delivery of Parts and Supplies for the vehicles of FDA (Per lot)
  • ITB and RFQ

NP-SVP(A)-2025-0184-ATQAL REPOST || Procurement of the Supply and Delivery of Laboratory Work Clothes, Footwear and Head Caps

December 12, 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of the Supply and Delivery of Laboratory Work Clothes, Footwear and Head Caps... Read More NP-SVP(A)-2025-0184-ATQAL REPOST || Procurement of the Supply and Delivery of Laboratory Work Clothes, Footwear and Head Caps
  • ITB and RFQ

NP-SVP(A)-2025-0193-ATQAL REPOST || Procurement of Calibration Service for X-ray Multimeter Mondel Unfors X2

December 12, 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Calibration Service for X-ray Multimeter Mondel Unfors X2 Read More NP-SVP(A)-2025-0193-ATQAL REPOST || Procurement of Calibration Service for X-ray Multimeter Mondel Unfors X2
  • ITB and RFQ

NP-SVP-2025-013-MIN || Procurement for the Supply and Delivery of Parts and Supplies for the vehicles of FDA (Per lot)

December 12, 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Supply and Delivery of Parts and Supplies for the vehicles of... Read More NP-SVP-2025-013-MIN || Procurement for the Supply and Delivery of Parts and Supplies for the vehicles of FDA (Per lot)
  • ITB and RFQ

NP-SVP-2025-018-MIN || Procurement for the Supply and Delivery of Office Supplies for various Offices of FDA (Per lot)

December 10, 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Supply and Delivery of Office Supplies for various Offices of FDA... Read More NP-SVP-2025-018-MIN || Procurement for the Supply and Delivery of Office Supplies for various Offices of FDA (Per lot)
  • ITB and RFQ

NP-SVP-2025-016-MEC || Supply and Delivery of Information and Communication Technology (ICT) Equipment for Mindanao East Cluster

December 10, 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Supply and Delivery of Information and Communication Technology (ICT) Equipment for Mindanao East Cluster... Read More NP-SVP-2025-016-MEC || Supply and Delivery of Information and Communication Technology (ICT) Equipment for Mindanao East Cluster
  • ITB and RFQ

NP-SVP-2025-015-MIN || Procurement of HVAC Maintenance Service Provider for the various offices of FDA

December 10, 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of HVAC Maintenance Service Provider for the various offices of FDA Read More NP-SVP-2025-015-MIN || Procurement of HVAC Maintenance Service Provider for the various offices of FDA
  • ITB and RFQ

NP-SVP-2025-009-MIN || Procurement for the Supply and Delivery of Furnitures for various Offices of FDA (Per lot)

December 10, 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Supply and Delivery of Furnitures for various Offices of FDA (Per... Read More NP-SVP-2025-009-MIN || Procurement for the Supply and Delivery of Furnitures for various Offices of FDA (Per lot)
  • ITB and RFQ
  • Uncategorized

RFQ_NP-SVP(A)-2025-0200-AFO || Supply and Delivery of Shirt

December 9, 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Supply and Delivery of Shirt Read More RFQ_NP-SVP(A)-2025-0200-AFO || Supply and Delivery of Shirt
  • ITB and RFQ

NP-SVP(A)-2025-0197-AFO || Procurement for the Supply and Delivery of Lights and Sound Systems Rental, including LED Wall, for the FDA Year-End Awards and Recognition on 05 December 2025 within FDA Alabang, Muntinlupa City

December 1, 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Supply and Delivery of Lights and Sound Systems Rental, including LED... Read More NP-SVP(A)-2025-0197-AFO || Procurement for the Supply and Delivery of Lights and Sound Systems Rental, including LED Wall, for the FDA Year-End Awards and Recognition on 05 December 2025 within FDA Alabang, Muntinlupa City View More

Latest Issuances

FDA Circular No.2025-007 || Guidelines on the Use of the Food and Drug Administration eServices Portal System for the Initial Application of a Certificate of Medical Device Notification (CMDN)
  • FDA Circular

FDA Circular No.2025-007 || Guidelines on the Use of the Food and Drug Administration eServices Portal System for the Initial Application of a Certificate of Medical Device Notification (CMDN)

December 16, 2025 I. RATIONALE Republic Act (RA) No. 9711  has empowered the Food and Drug Administration (FDA) to enhance and strengthen its... Read More FDA Circular No.2025-006 || IMPLEMENTATION OF ONLINE USER ACCOUNT REGISTRATION AND RENEWAL FOR FDA EPORTAL, EPORTAL2, AND RRDPORTAL WITHIN THE FDA ESERVICES PLATFORM
  • FDA Circular

FDA Circular No.2025-006 || IMPLEMENTATION OF ONLINE USER ACCOUNT REGISTRATION AND RENEWAL FOR FDA EPORTAL, EPORTAL2, AND RRDPORTAL WITHIN THE FDA ESERVICES PLATFORM

December 16, 2025 I. RATIONALE/BACKGROUND The Food and Drug Administration (FDA) had previously issued guidelines governing the application and use of FDA User... Read More Administrative Order No. 2025-0024 || Guidelines in Availing Compassionate Special Permit for the Restricted Use of Covered Pharmaceutical Products and Medical Devices for Human Use
  • Administrative Order
  • Drugs Advisories

Administrative Order No. 2025-0024 || Guidelines in Availing Compassionate Special Permit for the Restricted Use of Covered Pharmaceutical Products and Medical Devices for Human Use

November 26, 2025 Guidelines in Availing Compassionate Special Permit for the Restricted Use of Covered Pharmaceutical Products and Medical Devices for Human Use... Read More Department Circular No.2025-0382 || Extension of the Suspension Period Under Department Circular No. 2025-0240 entitled, “Temporary Suspension for Sixty (60) Working Days of the Implementation of Administrative Order No. 2024-0016 entitled, Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration”
  • FDA Circular

Department Circular No.2025-0382 || Extension of the Suspension Period Under Department Circular No. 2025-0240 entitled, “Temporary Suspension for Sixty (60) Working Days of the Implementation of Administrative Order No. 2024-0016 entitled, Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration”

September 10, 2025 The Department Circular (DC) No. 2025-0240, entitled "Temporary Suspension for Sixty (60) Working Days of the Implementation of Administrative Order... Read More FDA Circular No.2025-005 || Delisting of Purchase Booklet from the Checklist of Requirements to Avail of the 20% Senior Citizen Discount on the Purchase of Medicines and Medical Devices in Accordance with the Department of Health Administrative Order No. 2024-0017 Entitled, “Purchase Booklets No Longer Required for the 20% Senior Citizens’ Discount on Medicines, in Compliance with Republic Act No. 9994, Otherwise Known as “The Expanded Senior Citizens Act of 2010””
  • FDA Circular

FDA Circular No.2025-005 || Delisting of Purchase Booklet from the Checklist of Requirements to Avail of the 20% Senior Citizen Discount on the Purchase of Medicines and Medical Devices in Accordance with the Department of Health Administrative Order No. 2024-0017 Entitled, “Purchase Booklets No Longer Required for the 20% Senior Citizens’ Discount on Medicines, in Compliance with Republic Act No. 9994, Otherwise Known as “The Expanded Senior Citizens Act of 2010””

September 4, 2025 I. BACKGROUND Republic Act (RA) No. 9994 or the “Expanded Senior Citizens Act of 2010” was enacted to support the... Read More FDA Circular No.2025-004 || Adoption of Codex Standard for Follow-Up Formula for Older Infants and Product/Drink for Young Children (CXS 156-1987) as Technical Regulation
  • FDA Circular

FDA Circular No.2025-004 || Adoption of Codex Standard for Follow-Up Formula for Older Infants and Product/Drink for Young Children (CXS 156-1987) as Technical Regulation

July 14, 2025 I. BACKGROUND It is the State’s policy, as embodied in Article II, section 15 of the 1987 Constitution to protect... Read More FDA Circular No.2025-003 || Adoption of Codex Guidelines for Ready-To-Use Therapeutic Foods (RUTF) (CXG 95-2022) as Technical Regulation
  • FDA Circular

FDA Circular No.2025-003 || Adoption of Codex Guidelines for Ready-To-Use Therapeutic Foods (RUTF) (CXG 95-2022) as Technical Regulation

July 3, 2025 I. BACKGROUND Enshrined in the 1987 Constitution is the policy of the State to protect and promote the right to... Read More FDA Order No.2023-0790-B || Lifting the Temporary Ban on the Importation of Processed Pork Products from the Republic of Korea
  • Administrative Order
  • Food - Lifting Advisories

FDA Order No.2023-0790-B || Lifting the Temporary Ban on the Importation of Processed Pork Products from the Republic of Korea

June 16, 2025 In the interest of consistency and coherent efforts in preventing the entry of African Swine Fever Virus in the country,... Read More DEPARTMENT CIRCULAR NO.2025-0240 || Temporary Suspension for Sixty (60) Working Days of the Implementation of Administrative Order No. 2024-0016 entitled, “Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration”
  • FDA Circular

DEPARTMENT CIRCULAR NO.2025-0240 || Temporary Suspension for Sixty (60) Working Days of the Implementation of Administrative Order No. 2024-0016 entitled, “Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration”

June 11, 2025 Temporary Suspension for Sixty (60) Working Days of the Implementation of Administrative Order No. 2024-0016 entitled, "Implementing Guidelines on the... Read More FDA Circular No.2025-002 || Updates and Amendments to the ASEAN Cosmetic Directive (ACD) as Adopted during the 39th ASEAN Cosmetic Committee (ACC) Meeting and Its Related Meetings
  • FDA Circular

FDA Circular No.2025-002 || Updates and Amendments to the ASEAN Cosmetic Directive (ACD) as Adopted during the 39th ASEAN Cosmetic Committee (ACC) Meeting and Its Related Meetings

March 18, 2025 I. BACKGROUND In 2005, the Department of Health (DOH) – Food and Drug Administration (FDA), then Bureau of Food and... Read More View More
Quick Menus
Search

GMP

FDA ACADEMY

DOWNLOADABLES

CAREERS

FAQs

CONTACT US

Recent Posts

  • FDA Advisory No.2025-1536 || Product Recall of Specific Products Manufactured…

  • FDA Advisory No.2025-1607 || Public Health Warning Against the Purchase…

  • FDA Advisory No.2025-1606 || Public Health Warning Against the Purchase…

  • FDA Advisory No.2024-1289-A || Lifting the Advisory of the following…

Quick Links
  • Department of Health (DOH)
  • U.S Food and Drug Administration (U.S FDA)
  • Department of Information and Communications Technology (DICT)
  • Department of Science and Technology (DOST)
  • Anti-Red Tape Authority (ARTA)
Contact Information
Address:

Civic Drive Filinvest Corporate City

Alabang, Muntinlupa CityTel. no: (02) 8857-1900 local 1000[email protected]   Landline: (02)-8257-1957(02)-8286-6087(02)-8273-0481(02)-8800-4392(02)-8273-3756(02)-8659-7330
 
Email: [email protected]

Copyright © 2026. All Rights Reserved.

Shares

Từ khóa » Phi Fda